510(k) Report

510(k) · Cleared

Cleared

DSM Biomedical Calcium Phosphate Cement

K230054510(k) TraditionalCleared Mar 21, 202374-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dsm Biomedical · MQV Filler, Bone Void, Calcium Compound

Cleared on Mar 21, 2023 as substantially equivalent to K173362 (Kensey Nash Corporation Dba Dsm Biomedical, 2018) after a 74-day review. Its family tree reaches back 9 generations to 1987.

Decided
Mar 21, 2023
Review
74 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
1

Its longest line of descent runs back 9 generations to K873689 (1987). 19 ancestors in all, the oldest K861369 (1986). No later device cites it as a predicate yet.

  1. Root · 9 generations backK873689 Cranioplastic, Acrylic Cranioplasty MaterialDentsply Intl. · 1987
  2. 5 generations between
  3. 3 generations backK043334 Bone Source Hac Rapid Setting CementStryker Instruments · 2005
  4. 2 generations backK060061 Stryker Injectable CementStryker Corp. · 2006
  5. 1 generation backK173362 DSM Biomedical Calcium Phosphate CementKensey Nash Corporation Dba Dsm Biomedical · 2018
  6. This deviceK230054 DSM Biomedical Calcium Phosphate CementDsm Biomedical · 2023
Show all 9 generations
  1. Root · 9 generations backK873689 Cranioplastic, Acrylic Cranioplasty MaterialDentsply Intl. · 1987
  2. 8 generations backK953339 Bonesource Hydroxyapatite Cement (Hac)Osteogenics, Inc. · 1996
  3. 7 generations backK973789 Norian Cranial Repair System (CRS)Bone Cement- 5CC Kit, Norian…Norian Corp. · 1998
  4. 6 generations backK991398 Bonesource Hydroxyapatite Cement (Hac) Expanded KitStryker Leibinger · 1999
  5. 5 generations backK021440 Bonesource HacStryker Instruments · 2002
  6. 4 generations backK032366 Bonesource Hac Fast Setting CementStryker Instruments · 2003
  7. 3 generations backK043334 Bone Source Hac Rapid Setting CementStryker Instruments · 2005
  8. 2 generations backK060061 Stryker Injectable CementStryker Corp. · 2006
  9. 1 generation backK173362 DSM Biomedical Calcium Phosphate CementKensey Nash Corporation Dba Dsm Biomedical · 2018
  10. This deviceK230054 DSM Biomedical Calcium Phosphate CementDsm Biomedical · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K873689Cranioplastic, Acrylic Cranioplasty MaterialDentsply Intl.1987—
−8K953339Bonesource Hydroxyapatite Cement (Hac)Osteogenics, Inc.1996—
−7K973789Norian Cranial Repair System (CRS)Bone Cement- 5CC Kit, Norian Cranial Repair…Norian Corp.1998—
−6K991398Bonesource Hydroxyapatite Cement (Hac) Expanded KitStryker Leibinger1999—
−5K021440Bonesource HacStryker Instruments2002—
−4K032366Bonesource Hac Fast Setting CementStryker Instruments2003—
−3K043334Bone Source Hac Rapid Setting CementStryker Instruments2005—
−2K060061Stryker Injectable CementStryker Corp.2006—
−1K173362DSM Biomedical Calcium Phosphate CementKensey Nash Corporation Dba Dsm Biomedical2018—
0 (this device)K230054DSM Biomedical Calcium Phosphate CementDsm Biomedical2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
199210
199720
199910
200120
200210
200310
200410
FIG. 1 — Lineage of K230054, 1987–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K173362DSM Biomedical Calcium Phosphate Cement
Summary page 4
…Panel: Orthopedic III. PREDICATE DEVICE Substantial equivalence is claimed to the following device: • DSM Biomedical Calcium Phosphate Cement, K173362 IV. DEVICE DESCRIPTION Page 1 of 6 === P…
Kensey Nash Corporation Dba Dsm Biomedical2018—

Also cleared against K173362: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 36 years and passes through 8 companies; a new generation was cleared every 1.9 years on median.
  • 1 of the 19 ancestors has a recall of any class.
  • 1 other device also cites its predicate K173362.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

DSM Biomedical Calcium Phosphate Cement is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities and pelvis). These defects may be surgically created, or osseous defects created from traumatic injury to the bone. The Calcium Phosphate Cement is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The Calcium Phosphate Cement cured in situ provides an open void/gap filler that can…

Read the full statement (126 words)

DSM Biomedical Calcium Phosphate Cement is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities and pelvis). These defects may be surgically created, or osseous defects created from traumatic injury to the bone. The Calcium Phosphate Cement is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The Calcium Phosphate Cement cured in situ provides an open void/gap filler that can augment provisional hardware (e.g. K-Wires, plates, screws) to help support bone fragments during the surgical procedure. The cured cement acts only as a temporary support media and is not intended to provide structural support during the healing process. The Calcium Phosphate Cement resorbs and is replaced by bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K230054: DSM Biomedical Calcium Phosphate Cement.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K230054

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026